PTC THERAPEUTICS, INC.
PTCT
44 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Aug 21 9:20 PM | Michael SchmertzlerDirector | Sale | 12,500 | $73.32 | $916.6K | 1,374,094(I) | View → |
| Aug 17, 2026 | Aug 19 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 2,813 | $72.57 | $204.1K | 105,272(D) | View → |
| Aug 19, 2026 | Aug 19 8:51 PM | Michael Schmertzler | Proposed Sale | 50,000 | $73.00 | $3.6M | — | View → |
| Aug 17, 2026 | Aug 17 3:20 PM | Boulding Mark Elliott | Proposed Sale | 2,813 | $71.70 | $201.7K | — | View → |
| Aug 4, 2026 | Aug 6 9:20 PM | Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICER | Sale | 10,292 | $68.57 | $705.7K | 383,868(D) | View → |
| Aug 4, 2026 | Aug 4 7:11 PM | Klein Matthew B. | Proposed Sale | 10,292 | $68.57 | $705.8K | — | View → |
| Jul 14, 2026 | Jul 16 9:20 PM | Pierre GravierCHIEF FINANCIAL OFFICER | Sale | 3,494 | $80.35 | $280.7K | 83,986(D) | View → |
| Jul 14, 2026 | Jul 14 7:14 PM | Gravier Pierre | Proposed Sale | 3,494 | $80.35 | $280.7K | — | View → |
| Jul 9, 2026 | Jul 13 9:20 PM | Mary L. SmithDirector | Sale | 15,834 | $90.00 | $1.4M | 21,813(D) | View → |
| Jul 9, 2026 | Jul 13 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 2,464 | $90.25 | $222.4K | 60,299(D) | View → |
| Jul 9, 2026 | Jul 9 8:11 PM | Almstead Neil Gregory | Proposed Sale | 2,464 | $90.25 | $222.4K | — | View → |
| Jul 9, 2026 | Jul 9 4:18 PM | Smith Mary L. | Proposed Sale | 15,834 | $90.00 | $1.4M | — | View → |
| Jul 6, 2026 | Jul 8 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 5,079 | $85.08 | $432.1K | 105,272(D) | View → |
| Jul 7, 2026 | Jul 8 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 24,613 | $88.89 | $2.2M | 60,299(D) | View → |
| Jul 6, 2026 | Jul 8 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 22,161 | $86.00 | $1.9M | 60,299(D) | View → |
| Jul 7, 2026 | Jul 7 8:11 PM | Almstead Neil Gregory | Proposed Sale | 24,613 | $88.88 | $2.2M | — | View → |
| Jul 6, 2026 | Jul 6 8:10 PM | Almstead Neil Gregory | Proposed Sale | 22,161 | $86.00 | $1.9M | — | View → |
| Jul 6, 2026 | Jul 6 7:17 PM | Boulding Mark Elliott | Proposed Sale | 5,079 | $84.14 | $427.3K | — | View → |
| Jun 26, 2026 | Jun 30 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 8,130 | $85.26 | $693.2K | 60,137(D) | View → |
| Jun 25, 2026 | Jun 26 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 20,960 | $85.97 | $1.8M | 60,137(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Apr 8 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,265 | $39.42 | 6,798(D) | View → |
| Mar 24, 2026 | Mar 26 11:41 PM | Jessica Caroline ChutterDirector | Grant/Award | 6,371 | $64.54 | 2,896(D) | View → |
| Mar 10, 2026 | Mar 12 9:20 PM | Stephanie OkeyDirector | Option Exercise | 15,167 | $33.63 | 0(D) | View → |
| Feb 17, 2026 | Feb 19 10:25 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,813 | $25.69 | 22,501(D) | View → |
← Previous
Page 2 of 2